Willie Langston

Director Willie Langston buys 50,000 PSQH shares at $0.50; stock down -82.8% from 52-week high, company unprofitable with -21.5% revenue decline.

Willie Langston, a director, purchased 50,000 shares at $0.50 on 2026-06-08, increasing his holdings to 396,205 shares. The transaction occurs in a deeply distressed context: the stock trades at $0.49, down 82.8% from its 52-week high of $2.84, and the company is unprofitable with annual revenue declining 21.5% and the latest quarter showing a net loss of $6,454,937.00. Langston's cross-ticker track record shows 2 prior open-market buys with a 0.00% 90-day win rate; at PSQH specifically, his prior two buys (May 2025) produced 90-day returns of -6.2% and -4.3% respectively, neither well-timed at the 90-day mark. The purchase of 50,000 shares represents a 14.4% increase to his position, but comes as the company faces significant operational and revenue headwinds with minimal market capitalization of $23,875,936.98.

Director Langston Willie purchases 27,000 PSQH shares at $1.95, second buy in 7 days amid -74.6% decline from 52-week high.

Langston Willie executed a second open-market purchase of PSQH within one week, buying 27,000 shares at $1.95 on 2025-05-20 following a 30,000-share purchase on 2025-05-13. The timing occurs as the stock trades at $1.94, down -74.6% from its 52-week high of $7.63 and -41.4% over the prior 90 days despite a modest +5.4% recovery in the past 30 days. The company's fundamentals remain concerning: latest quarterly revenue of $6.7M with a net loss of $-4.4M, and while annual revenue growth of +759.7% indicates scale-up activity, the company remains unprofitable on a full-year basis. The director's back-to-back purchases at depressed levels, increasing his holdings by 10.9% to 274.8K shares, occur without measurable track record of well-timed accumulation at this ticker.

Director Langston Willie buys 25,000 shares of PSQH at $2.05; stock -73.9% from 52-week high but +759.7% revenue growth

Langston Willie, a Director, purchased 25,000 shares at $2.05 on 2025-05-13, increasing his holdings by 11.2% to 247,776 shares. The purchase occurs in a context of significant price weakness—the stock is -73.9% from its 52-week high of $7.63 and trading at $1.99 currently—but against a backdrop of explosive revenue growth of +759.7% year-over-year. However, the company remains unprofitable, with net income of $-4,447,345.00 ($-4.4M) in its most recent full fiscal year and $-4.4M in the latest quarter. The timing of this open-market purchase coincides with severe stock depreciation, yet the company's underlying revenue momentum is extraordinary; investors should evaluate whether the unprofitability reflects short-term scaling costs or structural business challenges.